Submit Deal

PEAK PHARMA

Summary

Peak Pharma is a CBC Group-controlled pharmaceutical company focused on acquiring and commercializing branded therapies in China, particularly in internal medicine and chronic diseases.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 79 M

Avg. Deal Size£ 79 M

Market Context

Senior Management

Soren Mogelsvang
CEO

Sort

28 Mar 2025|Japan|Pharmaceuticals

Target: EISAI (PARIET)

Bidder: CBC GROUP

4 Service Providers

3 Bidder | 1 Vendor

5 Dealmakers

4 Bidder | 1 Vendor

£ 79 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy